Skip to main content
. 2021 Feb 12;13(4):765. doi: 10.3390/cancers13040765
AR Androgen receptor
BC Breast cancer
BRCA1 Breast cancer type 1 susceptibility gene
CK 5/6 Cytokeratin 5/6
DC Dendritic cells
DNA Deoxyribonucleic acid
EGFR Epidermal growth factor receptor
ER Estrogen receptor
FOXA1 Forkhead box protein A1
HES Hematoxylin-Eosin-Saffron
HER2 Human epidermal growth factor receptor 2
HR Hazard ratio
IHC Immunohistochemistry
NK Natural killer
OS Overall survival
PCR Polymerase chain reaction
PD-1 Programmed cell death 1
PD-L1 Programmed cell death ligand 1
PR Progesterone receptor
REMARK Reporting recommendations for tumor marker prognostic studies
RFS Relapse-free survival
SC Stromal cells
TC Tumor cells
TCR T cell receptor
TIL Tumor infiltrating lymphocyte
TMA Tissue microarray
TNBC Triple-negative breast cancer